Biocon’s arm raises Rs 1125 crore through OCDs

10 Dec 2020 Evaluate

Biocon’s subsidiary company -- Biocon Biologics has raised Rs 1125 crore through Unlisted, Unsecured, Redeemable, Optionally Convertible Debentures (OCDs) and allotted 1,125 OCDs having face value of Rs 1 crore each. The board of directors at its meeting held on December 09, 2020 has approved and allotted the same.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

Biocon Share Price

392.80 4.55 (1.17%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×